skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery

(2757) Views  (395) Full article downloads

Authors: Margaret A Keller, Katrina Gwinn, Josefina Nash, Jonathan Horsford, Ran Zhang, et al

Published Date November 2007 Volume 2007:3(5) Pages 613 - 618
DOI: http://dx.doi.org/10.2147/NDT.S

Margaret A Keller1, Katrina Gwinn2, Josefina Nash1, Jonathan Horsford3, Ran Zhang2, Stephen S Rich4, Roderick A Corriveau1

1Coriell Institute for Medical Research, Camden, NJ, USA; 2National Institute for Neurological Disorders and Stroke-NIH, Bethesda, MD, USA; 3National Institute of Dental and Craniofacial Research-NIH, Bethesda, MD, USA; 4Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA

Abstract: Family history, which includes both common environmental and genetic effects, is associated with an increased risk for many neuropsychiatric diseases. Investigators have identified several disease-causing mutations for specific neuropsychiatric disorders that display Mendelian segregation. Such discoveries can lead to more rational drug design and improved intervention from a better understanding of the underlying biological mechanisms. However, a key challenge of genetic discovery in human complex diseases, including neuropsychiatric disorders, is that most diseases with genetic components display non-Mendelian patterns of inheritance. Recent advances in human population genetics include high-density genome-wide analyses of single nucleotide polymorphisms (SNPs) that make it possible to study complex genetic contributions to human disease. This approach is currently the most powerful strategy for analyzing the genetics of complex diseases. Genome-wide SNP analyses often require a large collaborative effort to collect, manage, and disseminate the numerous samples and corresponding clinical data. In this review we discuss the use of publicly available biorepositories for the collection and distribution of human genetic material, associated phenotypic information, and their use in genome-wide investigations of human neuropsychiatric diseases.

Keywords: repository, human, neurology, consent, genetics, bioinformatics








Readers of this article also read:

Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats
Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease
Varenicline in the treatment of tobacco dependence
Review of the clinical evidence for interferon β 1a (Rebif®) in the treatment of multiple sclerosis
Prolonged cholinergic enrichment influences regional cortical activation in early Alzheimer’s disease
Microarray oligonucleotide probe designer: a Web service
Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress
Genetics of osteoporotic fracture
Racial differences in the responses to shear stress in human umbilical vein endothelial cells
Gene expression for HIV-associated dementia and HIV encephalitis in microdissected neurons 1: preliminary analysis